Company: SXTPW
Filing Date: 2025-08-27
Form Type: DEF 14A
Source: 0001213900-25-080878
Chunk: 28

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-27
Form: DEF 14A
Chunk 28
---
 industry.

The Committee met four times during the fiscal
year ended 2024. The Committee schedules its meetings with a view to ensuring that it devotes appropriate attention to all of its tasks.
The Committee’s meetings generally include private sessions with the Company’s independent auditors and with the Company’s
internal auditors, in each case without the presence of the Company’s management, as well as executive sessions consisting of only
Committee members. In addition to the scheduled meetings, senior management confers with the Committee or its Chair from time to time,
as senior management deems advisable or appropriate, in connection with issues or concerns that arise throughout the year.

Management is responsible for the Company’s
financial reporting process, including its system of internal control over financial reporting, and for the preparation of consolidated
financial statements in accordance with accounting principles generally accepted in the United States. The Company’s independent
auditors are responsible for auditing those financial statements in accordance with professional standards and expressing an opinion as
to their material conformity with U.S. generally accepted accounting principles and for auditing the effectiveness of the Company’s
internal control over financial reporting. The Committee’s responsibility is to monitor and review the Company’s financial
reporting process and discuss management’s report on the Company’s internal control over financial reporting. It is not the
Committee’s duty or responsibility to conduct audits or accounting reviews or procedures. The Committee has relied, without independent
verification, on management’s representations that the financial statements have been prepared with integrity and objectivity and
in conformity with accounting principles generally accepted in the U.S. and that the Company’s internal control over financial reporting
is effective. The Committee has also relied, without independent verification, on the opinion of the independent auditors included in
their report regarding the Company’s financial statements and effectiveness of internal control over financial reporting.

<div align='center'>15</div>

Oversight Matters:As part of its oversight
of the Company’s financial statements, the Committee reviews and discusses with both management and the Company’s independent
auditors all annual and quarterly financial statements prior to their issuance. With respect to each 2024 fiscal reporting period, management
advised the Committee that each set of financial statements reviewed had been prepared in accordance with accounting principles generally
accepted in the U.S., and reviewed significant accounting and disclosure issues with the Committee. These reviews included discussions
with the independent auditors of matters required to be discussed pursuant to Public Company Accounting Oversight Board (“PCAOB”)
Auditing Standard No.